Dupixent subcutaneous injection 200 mg syringe, manufactured by Sanofi, contains dupilumab (genetical recombination), a monoclonal antibody used to treat various inflammatory conditions. These include moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. It is supplied as 200mg 1.14mL 1 tube with YJ code 4490405G3027.
Dupixent subcutaneous injection 200 mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →